| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |